NeuScience Launches Fundraising for Cancer Drug Discovery AI Platform
When AOL co-founder Steve Case kicked off San Antonio Startup Week 2022 with his keynote address in October, no one expected him to mention a local startup. Case, now chairman and CEO of Revolution, a Washington-based investment firm that backs entrepreneurs, told the audience how he has invested in a San Antonio biotechnology company — NeuScience.NeuScience is an artificial intelligence (AI) drug discovery startup in Revolution’s investment portfolio. Its CEO and co-founder Guillermo Vela connected with Case and his Rise of the Rest fund at a Techstars 2019 event.NeuScience’s AI-driven platform works with computer vision to detect unique markers for cancer. Computer vision can “see” in more detail the unique phenotypic signatures that are biomarkers for cancer tumors.Vela ...